Izzy Brown

(she/her) • Johns Hopkins University, BS 2018 • Eastern Virginia Medical School, MD 2024

[Dr. Shawn Kwatra @drshawnkwatra]

Excited to be speaking at #aad2024 and sharing my insights on all things #itch #eczema #prurigo. Hope to see many of you there!

[Izzy Brown @IzzyB_96]

@drshawnkwatra @UMmedschool @HopkinsMedicine Congratulations, such exciting news!!!

[Izzy Brown @IzzyB_96]

So excited to have gotten the opportunity to share my research with Dr. @DerberCatherine on V. Vulnificus nec fasc at #ACP2023 Thank you @ACPIMPhysicians !!

[Hannah Cornman @HannahCornman]

My first publication as a 1st author in Derm 😊 we found 4x higher prevalence of TB in patients with prurigo nodularis and suggest TB testing during initial PN work up could be beneficial for patient management. https://t.co/j0ujAXJxMI
@drshawnkwatra @AnushaKambala @sriyavreddy

[Izzy Brown @IzzyB_96]

@drshawnkwatra @waleedadawi96 @SkinOfColor @nationaleczema Congrats to the team!! This is amazing work

[Dr. Shawn Kwatra @drshawnkwatra]

Excited to share our team’s latest work led by @waleedadawi96 on the various presentations of #eczema in @SkinOfColor patients https://t.co/WqhchiSxds. Looking forward to keep advocating for #diversity in new leadership roles @SkinOfColor & @nationaleczema #dermtwitter

[Dr. Shawn Kwatra @drshawnkwatra]

Jak inhibitors are emerging in so many dermatology diseases & gaining approvals w/cross immune-axis activity (Th1,2,17,22). But there’s a lot to think about at the bedside with pts. Here’s our approach to risk stratification & lab monitoring https://t.co/KCw0mRml6R #dermtwitter

[Uzoma Ahiarakwe, MD, MS @uzimedfit]

Excited about this one, as I was again able to align my interest and my work. #MedTwitter https://t.co/F036cT0CdW

[Dr. Shawn Kwatra @drshawnkwatra]

In multi-center analysis, we find PN patients are at an increased risk of many CAF-malignancies including breast and colorectal cancer and squamous cell carcinoma as well as other fibrotic disorders (makes sense since CAFs are also present in PN non-lesional skin).

[Bryan Carmody @jbcarmody]

I don’t usually brag about our residency program, but today I’m gonna make an exception.

Like other children’s hospitals, we’re managing a surge in respiratory illness.

But unlike most hospitals, we’re gonna pay the residents who work extra overnight/weekend shifts $100/hour.

[Kelly Kimball, MD @kellymkimball]

Our next @DermTalks lecture will be this Monday, October 31st, and will feature @drshawnkwatra from @JohnsHopkins. He will be speaking about his research on prurigo nodularis …be sure to sign up here 🌎🌍🌏 ➡️ https://t.co/IvUylMdx6q

[Uzoma Ahiarakwe, MD, MS @uzimedfit]

Thank you to the @AmerMedicalAssn for allowing me to cross my love for Orthopaedic surgery and Addiction medicine in their poster symposium. #MedTwitter

[Dr. Shawn Kwatra @drshawnkwatra]

Today is a big day for #prurigo nodularis patients! Fresh off the press https://t.co/4QjtaMzRm9, dupilumab was minutes ago #fda approved for PN. This is just the start, with other agents in late stage development with exciting data. It’s the golden age for #PN #dermtwitter

[Catherine Read @thecatread]

Spent an amazing week @OrthoSummit and met some of my absolute heroes! It was an honor to be invited to present my work with @_CHKD and @EVMSedu. So grateful to @lisacannada and the OSET team for this opportunity

#orthotwitter #womeninortho #ladypod #orthopaedics #OSET2022 #OSET

[Dr. Shawn Kwatra @drshawnkwatra]

Happening now - just announced @HopkinsMedicine Dermatology Graduation that @c_vasavda from our lab wins the Stanford I. Lambert Research Prize in Dermatology, including a $2500 cash prize for his oral presentation on the genetic basis of #prurigo nodularis #dermtwitter

[Dr. Shawn Kwatra @drshawnkwatra]

Lots of credit to our multidisciplinary team:
Oncology - @DrJNaidoo, @JulieBrahmer, @kreynoldsMD, @vivek_naranbhai
Rheumatology - @cappelliMD
And of course Dermatology - @EugeneSemenovMD
& the whole team - Thomas Le, @vparthas @IzzyB_96 @JuneDeng10, etc

[Dr. Shawn Kwatra @drshawnkwatra]

Happy to share the results of our global pharmacovigilance study on the development of cutaneous toxicities during treatment with immune checkpoint inhibitors (NCT04898751) published in @JIDJournals https://t.co/mc00JykwbL #dermtwitter

[Chirag Vasavda @c_vasavda]

huge congratulations!! to @JuneDeng10 @vparthas @waleedadawi96 @NishadhSutaria @IzzyB_96 @EugeneSemenovMD @drshawnkwatra et al on this study underscoring the value of undifferentiated pruritus as a powerful diagnostic clue

https://t.co/bbm87Wc3Y6 @JAMADerm @HopkinsMedicine

[Varsha Parthasarathy, M.D. @vparthas]

Our lab @drshawnkwatra has a big day ahead at #SID2022 with 3 talks in the clinical/interventional research & @SkinOfColor concurrent minisymposia @SocInvestDerm #dermtwitter!